ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2020

The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type 2 Diabetes: A Cost of Control Analysis in Spain.

Josep Vidal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.